CEACAM5 and neoplasm: As described earlier, conventional protein tumor markers such as carcinoembryonic antigen (CEA), cancer antigens 15-3 (CA15-3) or 19-9 (CA19-9), are routinely used in clinical practice, but they suffer from low sensitivity, especially at early stages, and are not routinely used for screening [128].